CoChat

Proton pump inhibitor‐induced acute interstitial nephritis

Open access
Härmark, Linda, Van Der Wiel, Hans E., De Groot, Mark C. H., Van Grootheest, A. C. · 2007 · British Journal of Clinical Pharmacology
Cited by 103

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

What is already known about this subject • In several case reports the use of omeprazole has been associated with interstitial nephritis. • Recently there have been reports linking other proton pump inhibitors (PPIs) with interstitial nephritis. What this study adds • We present supplementary cases received by the Netherlands Pharmacovigilance Centre Lareb, concerning interstitial nephritis in users of PPIs including omeprazole, pantoprazole and rabeprazole. • In this case series seven patients are presented. In six cases they recovered spontaneously after cessation of the PPI, in one case the patient recovered after treatment with a corticosteroid. • Further support for this association comes from the worldwide adverse drug reaction database of the World Health Organization. • This report shows that interstitial nephritis can occur with all PPIs. Health professionals should be aware of this potential serious adverse drug reaction. Aim: To investigate the association between the use of proton pump inhibitors (PPIs) and acute interstitial nephritis (AIN). Methods: The Netherlands Pharmacovigilance Centre Lareb received seven case reports of AIN induced by various PPIs. In five of the reports it was mentioned that the diagnosis was confirmed by a renal biopsy. Results: The time to onset varied between hours to 4 months. In all cases but one the patient spontaneously recovered after withdrawal of the offending agent. In one case the patient received treatment with prednisolone and recovered. In one patient a rechallenge was done 9 days after the initial event. Within 12 h of re‐exposure the patient developed symptoms of AIN. Conclusions: The mechanism of drug‐induced AIN is unknown, but an immunological mechanism is suspected. Our reports show no relation between dosage, latency, time to recovery, age or gender, supporting the hypothesis that the aetiology of AIN is immunological. Lareb has received reports of AIN with the use of omeprazole, pantoprazole and rabeprazole. This shows that AIN is a complication associated with the whole group of PPIs and not only omeprazole. It is important for health professionals to be aware of this adverse drug reaction, because an accurate and timely diagnosis and withdrawal of the offending drug can prevent potentially life‐threatening renal failure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.2007.02927.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 103

Metadata

Authors
Härmark, L., Van Der Wiel, H. E., De Groot, M. C. H., & Van Grootheest, A. C.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2007-07-17
Volume
64
Issue
6
Pages
819-823
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W2138193587
Cited by
103
References
4
FWCI
4.41
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proton pump inhibitor‐induced acute interstitial nephritis. https://app.cochat.ai/papers/10.1111/j.1365-2125.2007.02927.x
The paper
Härmark, L., Van Der Wiel, H. E., De Groot, M. C. H., & Van Grootheest, A. C. (2007). Proton pump inhibitor‐induced acute interstitial nephritis. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2007.02927.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.